Medications for Overactive Urinary Bladder

12 results
  • darifenacin

    (Darifenacin Hydrobromide)
    POLYGEN PHARMACEUTICALS INC.
    Darifenacin extended-release tablets are indicated for the treatment of overactive bladder, specifically for managing symptoms of urge urinary incontinence, urgency, and frequency.
  • fesoterodine fumarate

    (Fesoterodine Fumarate)
    Ascend Laboratories, LLC
    Fesoterodine fumarate extended-release tablets are indicated for treating overactive bladder (OAB) in adults, specifically for symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information exists but is not included due to marketing exclusivity rights.
  • oxybutynin chloride

    (Oxybutynin Chloride)
    Novitium Pharma LLC
    Oxybutynin chloride tablets are indicated for relieving bladder instability symptoms, including urgency, frequency, urinary leakage, urge incontinence, and dysuria, in patients with uninhibited neurogenic or reflex neurogenic bladder.
  • solifenacin succinate

    (SOLIFENACIN SUCCINATE)
    ScieGen Pharmaceuticals, Inc.
    Solifenacin succinate is indicated for treating adults with overactive bladder, specifically addressing symptoms of urge urinary incontinence, urgency, and urinary frequency.
  • solifenacin succinate

    (Solifenacin Succinate)
    Aurobindo Pharma Limited
    Solifenacin succinate tablets are indicated for treating overactive bladder in adults, addressing symptoms such as urge urinary incontinence, urgency, and urinary frequency.
  • solifenacin succinate

    (Solifenacin Succinate)
    Alembic Pharmaceuticals Inc.
    Solifenacin succinate is indicated for treating adults with overactive bladder, specifically addressing symptoms of urge urinary incontinence, urgency, and urinary frequency.
  • solifenacine succinate

    (solifenacine succinate)
    Cipla USA Inc.
    Solifenacin succinate is indicated for treating adults with overactive bladder, specifically addressing symptoms of urge urinary incontinence, urgency, and urinary frequency.